Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: Results of the international randomised LY03 trial

British Journal of Haematology

Volumn 144, Issue 3, 2009, Pages 367-375

  Hancock, Barry W ^a   Qian, Wendi ^b   Linch, David ^c   Delchier, Jean Charles ^d   Smith, Paul ^c   Jakupovic, Ira ^c   Burton, Cathy ^c   Souhami, Robert ^c   Wotherspoon, Andrew ^e   Copie Bergman, Christiane ^d   Capella, Carlo ^f   Traulle, Catherine ^g   Levy, Michael ^d   Cortelazzo, Sergio ^h   Ferreri, Andres J M ⁱ   Ambrosetti, Achille ^j   Pinotti, Graziella ^f   Martinelli, Giovanni ^k   Vitolo, Umberto ^l   Cavalli, Franco ^m   Gisselbrecht, Christian ⁿ   Zucca, Emanuele ^m   more..

^a WESTON PARK HOSPITAL   (United Kingdom)

^b MRC CLINICAL TRIALS UNIT   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d HENRI MONDOR HOSPITAL   (France)

^e ROYAL MARSDEN HOSPITAL   (United Kingdom)

^f OSPEDALE DI CIRCOLO   (Italy)

^g CENTRE HOSPITALIER LYON SUD   (France)

^h CENTRAL HOSPITAL OF BOLZANO   (Italy)

ⁱ SAN RAFFAELE HOSPITAL   (Italy)

^j Policlinico GB Rossi   (Italy)

^k EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^l MOLINETTE HOSPITAL   (Italy)

^m ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

ⁿ SAINT LOUIS HOSPITAL   (France)

more..

Author keywords

Chemotherapy; Chlorambucil; Gastric MALT lymphomas; Observation; Randomised controlled trial

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMBUCIL;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; STOMACH LYMPHOMA; STOMACH MUCOSA; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; CHLORAMBUCIL; DISEASE-FREE SURVIVAL; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 58449099347     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07486.x     Document Type: Article

References (23)

1. Bayerdorffer, E., Neubauer, A., Rudolph, B., Thiede, C., Lehn, N., Eidt, S. Stolte, M. (1995) Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet, 345, 1591 1594.
2. Bertoni, F. Zucca, E. (2005) State-of-the-art therapeutics:marginal-zone lymphoma. Journal of Clinical Oncology, 23, 6415 6420.
3. Bertoni, F., Conconi, A., Capella, C., Motta, T., Giardini, R., Ponzoni, M., Pedrinis, E., Novero, D., Rinaldi, P., Cazzaniga, G., Biondi, A., Wotherspoon, A., Hancock, B., Smith, P., Souhami, R., Cotter, F., Cavalli, F. Zucca, E. (2002) International Extranodal Lymphoma Study Group and United Kingdom Lymphoma Group. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 co-operative trial. Blood, 99, 2541 2544.
4. Chini, C., Pinotti, G., Stathis, A., Proserpio, I., Bertoni, F., Cavalli, F. Zucca, E. (2007) Long term outcome of gastric MALT lymphoma patients treated with anti-Helicobacter (antibiotic and proton-pump inhibitor) regimens. Blood ASH Annual Meeting Abstracts) 110, 761a (Abs.# 2583).
5. Copie-Bergman, C. Wotherspoon, A. (2008) MALT lymphoma pathology, initial diagnosis, and posttreatment evaluation. In : Extranodal Lymphomas Pathology and Management (ed. by F. Cavalli, H. Stein E. Zucca pp. 114 123. Informa Health Care, London.
6. Ferrucci, P. Zucca, E. (2007) Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? British Journal of Haematology, 136, 521 538.
7. Fischbach, W., Goebeler, M.E., Ruskone-Fourmestraux, A., Wundisch, T., Neubauer, A., Raderer, M. Savio, A. (2007) Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut, 56, 1685 1687.
8. Hammel, P., Haioun, C., Chaumette, M.T., Gaulard, P., Divine, M., Reyes, F. Delchier, J.C. (1995) Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. Journal of Clinical Oncology, 13, 2524 2529.
9. Isaacson, P.G. Spencer, J. (1987) Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology, 11, 445 462.
10. Isaacson, P.G. Wright, D.H. (1983) Malignant lymphoma of mucosa associated lymphoid tissue: a distinctive type of B-cell lymphoma. Cancer, 52, 1410 1416.
11. Koch, P., Probst, A., Berdel, W.E., Willich, N.A., Reinartz, G., Brockmann, J., Liersch, R., del Valle, F., Clasen, H., Hirt, C., Breitsprecher, R., Schmits, R., Freund, M., Fietkau, R., Ketterer, P., Freitag, E.M., Hinkelbein, M., Heinecke, A., Parwaresch, R. Tiemann, M. (2005) Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). Journal Clinical Oncology, 23, 7050 7059.
12. Levy, M., Copie-Bergman, C., Cameiro, C., Chaumette, M., Delfau-Larue, M., Haioun, C., Charachon, A., Hemery, F., Caulard, P., Leroy, K. Delchier, J.C. (2005) Prognostic value of translocation t(11;18) in tumour response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. Journal of Clinical Oncology, 23, 5061 5066.
13. Liu, H., Ye, H., Ruskone-Fourmestraux, A., De Jong, D., Pileri, S., Thiede, C., Lavergne, A., Boot, H., Caletti, G. Wundisch, T. (2002) T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology, 122, 1286 1294.
14. Martinelli, G., Laszlo, D., Ferreri, A.J., Pruneri, G., Ponzoni, M., Conconi, A., Crosta, C., Pedrinis, E., Bertoni, F., Calabrese, L. Zucca, E. (2005) Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. Journal of Clinical Oncology, 23, 1979 1983.
15. Pinotti, G., Zucca, E., Roggero, E., Pascarella, A., Bertoni, F., Savio, A., Savio, E., Capella, C., Pedrinis, E., Saletti, P., Morandi, E., Santandrea, G. Cavalli, F. (1997) Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leukemia and Lymphoma, 26, 527 537.
16. Roggero, E., Zucca, E., Pinotti, G., Pascarella, A., Capella, C., Savio, A., Pedrinis, E., Paterlini, A., Venco, A. Cavalli, F. (1995) Eradication of Helicobacter pylori infection in primary low- grade gastric lymphoma of mucosa-associated lymphoid tissue. Annals of Internal Medicine, 122, 767 769.
17. Rohatiner, A., d'Amore, F., Coiffier, B., Crowther, D., Gospodarowicz, M., Isaacson, P., Lister, T.A., Norton, A., Salem, P. Shipp, M. (1994) Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Annals of Oncology, 5, 397 400.
18. Ruskone-Fourmestraux, A., Lavergne, A., Aegerter, P.H., Megraud, F., Palazzo, L., de Mascrarel, A., Molina, T. Rambaud, J.L. (2001) Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut, 48, 297 303.
19. Stolte, M., Bayerdorffer, E., Morgner, A., Alpen, B., Wundish, T., Thiede, C. Neubauer, A. (2002) Helicobacter and gastric MALT lymphoma. Gut, 50, 19 24.
20. Wotherspoon, A.C., Ortiz-Hidalgo, C., Falzon, M.R. Isaacson, P.G. (1991) Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet, 338, 1175 1176.
21. Wotherspoon, A.C., Doglioni, C., Diss, T.C., Pan, L., Moschini, A., De Boni, M. Issacson, P.G. (1993) Regression of primary low grade B-cell gastric lymphoma of mucosa associated lymphoid tissue (MALT) type following eradication of Helicobacter pylori. Lancet, 342, 575 577.
22. Wundisch, T., Thiede, C., Morgner, A., Dempfle, A., Gunther, A., Liu, H., Ye, H., Du, M.Q., Kim, T.D., Bayerdorffer, E., Stolte, M. Neubauer, A. (2005) Long-term follow-up of gastric MALT after Helicobacter pylori eradication. Journal of Clinical Oncology, 23, 8018 8024.
23. Yoon, S.S., Coit, D.G., Portlock, C.S. Karpeh, M.S. (2004) The diminishing role of surgery in the treatment of gastric lymphoma. Annals of Surgery, 240, 28 37.